The effect of NSAID for the cystoid macular edema after panretinal photocoagulation in diabetic retinophathy
Not Applicable
- Conditions
- diabetic retinopathy
- Registration Number
- JPRN-UMIN000001646
- Lead Sponsor
- Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
Cannot recieve informed concent. Treated by NSAID for these 6 months. Already recieved panretinal photocoagulation. Treated photocoagulation except pan retinal photocoagulation for these 6 months. Not suitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie NSAID efficacy in reducing cystoid macular edema post-panretinal photocoagulation for diabetic retinopathy?
How does NSAID treatment compare to corticosteroids in managing post-photocoagulation macular edema in diabetic retinopathy patients?
Which biomarkers correlate with NSAID response in diabetic retinopathy-induced cystoid macular edema following panretinal photocoagulation?
What are the potential adverse events associated with long-term NSAID use in diabetic retinopathy patients post-photocoagulation?
Are there combination therapies involving NSAIDs that improve outcomes for cystoid macular edema in proliferative diabetic retinopathy?